Terms: = Lymphoma AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Clinical Outcome
11 results:
1. Clinicopathological and molecular features of indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract.
Yi H; Li A; Ouyang B; Da Q; Dong L; Liu Y; Xu H; Zhang X; Zhang W; Jin X; Gu Y; Wang Y; Liu Z; Wang C
Histopathology; 2023 Mar; 82(4):567-575. PubMed ID: 36494712
[TBL] [Abstract] [Full Text] [Related]
2. Phosphorylated stat3 expression predicts better prognosis in smoldering type of adult T-cell leukemia/lymphoma.
Morichika K; Karube K; Kayo H; Uchino S; Nishi Y; Nakachi S; Okamoto S; Morishima S; Ohshiro K; Nakazato I; Fukushima T; Masuzaki H
Cancer Sci; 2019 Sep; 110(9):2982-2991. PubMed ID: 31237072
[TBL] [Abstract] [Full Text] [Related]
3. Promoter methylation and expression of SOCS3 affect the clinical outcome of pediatric acute lymphoblastic leukemia by JAK/STAT pathway.
Liu K; Wu Z; Chu J; Yang L; Wang N
Biomed Pharmacother; 2019 Jul; 115():108913. PubMed ID: 31054507
[TBL] [Abstract] [Full Text] [Related]
4. LMP1+SLAMF1high cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells.
Yoon H; Ko YH
Oncotarget; 2017 Apr; 8(15):24621-24634. PubMed ID: 28445949
[TBL] [Abstract] [Full Text] [Related]
5. Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell lymphoma.
Hidalgo Lopez JE; Yabe M; Carballo-Zarate AA; Wang SA; Jorgensen JL; Ahmed S; Lee J; Li S; Schlette E; McDonnell T; Miranda RN; Medeiros LJ; Bueso-Ramos CE; Yin CC
J Natl Compr Canc Netw; 2016 Aug; 14(8):939-44. PubMed ID: 27496109
[TBL] [Abstract] [Full Text] [Related]
6. Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of "germinotropic" lymphoproliferative disorder.
Lorenzi L; Lonardi S; Essatari MH; Pellegrini V; Fisogni S; Gazzola A; Agostinelli C; Vermi W; Rossi G; Massarelli G; Pileri SA; Facchetti F
Virchows Arch; 2016 Apr; 468(4):441-50. PubMed ID: 26762526
[TBL] [Abstract] [Full Text] [Related]
7. Novel players in multiple myeloma pathogenesis: role of protein kinases CK2 and GSK3.
Piazza F; Manni S; Semenzato G
Leuk Res; 2013 Feb; 37(2):221-7. PubMed ID: 23174190
[TBL] [Abstract] [Full Text] [Related]
8. Autosomal dominant stat3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
Chandesris MO; Melki I; Natividad A; Puel A; Fieschi C; Yun L; Thumerelle C; Oksenhendler E; Boutboul D; Thomas C; Hoarau C; Lebranchu Y; Stephan JL; Cazorla C; Aladjidi N; Micheau M; Tron F; Baruchel A; Barlogis V; Palenzuela G; Mathey C; Dominique S; Body G; Munzer M; Fouyssac F; Jaussaud R; Bader-Meunier B; Mahlaoui N; Blanche S; Debré M; Le Bourgeois M; Gandemer V; Lambert N; Grandin V; Ndaga S; Jacques C; Harre C; Forveille M; Alyanakian MA; Durandy A; Bodemer C; Suarez F; Hermine O; Lortholary O; Casanova JL; Fischer A; Picard C
Medicine (Baltimore); 2012 Jul; 91(4):e1-e19. PubMed ID: 22751495
[TBL] [Abstract] [Full Text] [Related]
9. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.
Schlette EJ; Medeiros LJ; Goy A; Lai R; Rassidakis GZ
J Clin Oncol; 2004 May; 22(9):1682-8. PubMed ID: 15117990
[TBL] [Abstract] [Full Text] [Related]
10. Differential expression and clinical significance of tyrosine-phosphorylated stat3 in ALK+ and ALK- anaplastic large cell lymphoma.
Khoury JD; Medeiros LJ; Rassidakis GZ; Yared MA; Tsioli P; Leventaki V; Schmitt-Graeff A; Herling M; Amin HM; Lai R
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3692-9. PubMed ID: 14506160
[TBL] [Abstract] [Full Text] [Related]
11. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays.
García JF; Camacho FI; Morente M; Fraga M; Montalbán C; Alvaro T; Bellas C; Castaño A; Díez A; Flores T; Martin C; Martinez MA; Mazorra F; Menárguez J; Mestre MJ; Mollejo M; Sáez AI; Sánchez L; Piris MA;
Blood; 2003 Jan; 101(2):681-9. PubMed ID: 12393683
[TBL] [Abstract] [Full Text] [Related]
